Alphalyse

Alphalyse is a specialist contract research organization that supports biopharmaceutical companies in their process development and manufacturing of patient-safe products such as mAbs, vaccines, recombinant proteins, and cell and gene therapies.

We are agile, flexible and can quickly adjust to specific customer demands. We build strong and rewarding relationships with our customers and help them to develop well-characterized biologics by challenging and improving analysis methods using top-of-the-line mass spectrometry technology (LC-MS).

Since 2002, our scientists have completed over 10,000 protein characterization analyses, including forced degradation studies, and more than 400 LC-MS based residual protein and host cell protein projects. We understand that many drug developers perceive mass spectrometry as complex. Our team of experts focuses on making the results accessible to understand, and to use for data-driven process development and regulatory documentation under ICH Q6B guidelines.